Former Osiris Therapeutics executive pleads guilty to false statements
November 02, 2017 at 18:49 PM EDT
NEW YORK, Nov 2 (Reuters) - A former chief financial officer of biotechnology company Osiris Therapeutics on Thursday pleaded guilty to making false statements to auditors to inflate the company's reported revenue.
